Radar de Estudos Clínicos | Bavarian Nordic

Avançado

IA Trial Radar Candidato a Estudo ou Paciente Cuidador de Paciente Profissional de Saúde Profissional de Biotecnologia Investidor em Biotecnologia Pesquisador Outro
	Vamos discutir e explorar os estudos clínicos com Bavarian Nordic como patrocinador líder ou colaborador. Posso ajudar você a entender condições de saúde, tratamentos ou encontrar estudos clínicos próximos.

Nossa ferramenta de busca suporta apenas o inglês. Para pesquisa e discussão em outros idiomas, use a IA Trial Radar acima ou selecione filtros de condições médicas e locais abaixo.

Pesquisar por local, centro...

Pesquisar por palavras-chave...

Título do estudo	Status
An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults NCT07467707	Ainda não recrutando
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells NCT07199569	Em recrutamento
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. NCT07003984	Em recrutamento
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine NCT06899802	Ativo, não recrutando
Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC (PregInPoxVac) NCT06844500	Ativo, não recrutando
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC (PregInPoxVac) NCT06844487	Em recrutamento
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination NCT06007183	Ativo, não recrutando
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years NCT05349617	ConcluídoResultados publicados
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 NCT05329220	ConcluídoResultados publicados
MVA-BN-RSV Vaccine Trial NCT05238025	InterrompidoResultados publicados
ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects NCT05077267	ConcluídoResultados publicados
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) NCT05072080	ConcluídoResultados publicados
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine (CHIKV VLP) NCT05065983	ConcluídoResultados publicados
Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults NCT04752644	Concluído
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer NCT04246671	Concluído
A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer NCT04134312	Concluído
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects NCT04131595	Concluído
Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) (WRAIR) NCT03992872	ConcluídoResultados publicados
Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial NCT03699124	ConcluídoResultados publicados
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer NCT03628716	ConcluídoResultados publicados
Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix NCT03610581	InterrompidoResultados publicados
BN Brachyury and Radiation in Chordoma NCT03595228	ConcluídoResultados publicados
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC NCT03547999	InterrompidoResultados publicados
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer NCT03532217	Concluído
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults NCT03483961	ConcluídoResultados publicados
Special Access Program IMVAMUNE® NCT03472014	ConcluídoResultados publicados
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma NCT03376659	InterrompidoResultados publicados
Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury) NCT03349983	Concluído
VAXCHORA Pediatric Study to Assess Safety and Immunogenicity NCT03220737	ConcluídoResultados publicados
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo NCT02977715	Ativo, não recrutando
RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults NCT02873286	ConcluídoResultados publicados
RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults. NCT02864628	Retirado
A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer NCT02840994	Concluído
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy NCT02772562	InterrompidoResultados publicados
Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo NCT02661464	InterrompidoResultados publicados
Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer NCT02506114	InterrompidoResultados publicados
Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine NCT02419391	Concluído
Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers NCT02391909	Concluído
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults NCT02100631	ConcluídoResultados publicados
A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults NCT02094586	ConcluídoResultados publicados
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection NCT02038881	ConcluídoResultados publicados
A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000® NCT01913353	ConcluídoResultados publicados
Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera NCT01895855	ConcluídoResultados publicados
A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects NCT01668537	ConcluídoResultados publicados
Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 NCT01585181	Concluído
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer (Prospect) NCT01322490	ConcluídoResultados publicados
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy NCT01152398	Concluído

Fase

Tipo

Tipo de estudo

Faixa etária

Sexo

Placebo

Fase

Tipo

Tipo de estudo

Faixa etária

Sexo